RESUMEN
This paper describes a method for preparing a circular planar source of 17 mm diameter containing approximately 400 kBq of (147)Pm employing a wet chemical deposition technique to be used in dust monitors. This manuscript described the overall process concept and experimental procedure. The technical feasibility, efficiency of the process and product quality has been evaluated. The quality of the prepared source in terms of nonleachability, uniform distribution of activity and stability, which are necessary attributes of a radioactive source were evaluated and found to be satisfactory.
Asunto(s)
Contaminantes Atmosféricos/análisis , Prometio/química , Control de CalidadRESUMEN
Data on the distribution and redistribution patterns in the laboratory rat of three trivalent elements with a similar ionic radius have been compared. This showed that these distributions for the two ions with the same ionic radius (111 pm), i.e., those of promethium (a lanthanoid) and curium (an actinoid), were indistinguishable and that americium, with a slightly larger ion size (111.5 pm), behaved similarly. The results are consistent with the suggestion that ion size is the only important factor controlling the deposition and redistribution patterns of trivalent lanthanoids and actinoids in rats. The result is important because it suggests that the same radiological protection dosimetry models should be used for trivalent actinoids and lanthanoids, that human volunteer data generated for lanthanoid isotopes can be used to predict the behavior of actinoids with the same ion size, and that appropriate pairs of beta-particle-emitting lanthanoid and alpha-particle-emitting actinoids could be used to study the relative toxicity of alpha and beta particles in experimental animals.
Asunto(s)
Americio/farmacocinética , Curio/farmacocinética , Prometio/farmacocinética , Americio/química , Animales , Curio/química , Femenino , Iones , Cinética , Tasa de Depuración Metabólica , Especificidad de Órganos , Tamaño de la Partícula , Prometio/química , Ratas , Ratas Wistar , Distribución TisularRESUMEN
The radiolanthanides 149Pm, 166Ho, and 177Lu have decay characteristics suitable for radioimmunotherapy (RIT) of cancer. N-Hydroxysulfosuccinimidyl DOTA (DOTA-OSSu) and methoxy-DOTA (MeO-DOTA) were conjugated to the anti-TAG-72 monoclonal antibody CC49 for radiolabeling with 149Pm, 166Ho, and 177Lu. While both DOTA conjugates could be labeled to high specific activity with 177Lu, MeO-DOTA afforded superior conjugate stability, radiolabeling, and radiochemical purity. Pilot biodistributions in nude mice bearing LS174T human colon carcinoma xenografts demonstrated that MeO-DOTA afforded higher tumor uptake and lower kidney retention of 177Lu than DOTA-OSSu. The in vitro stability of 149Pm-, 166Ho-, and 177Lu-MeO-DOTA-CC49 was evaluated using serum and hydroxyapatite assays. Serum stability of radiolanthanide-labeled MeO-DOTA-CC49 followed a trend based on the coordination energies of the radiometals, with 177Lu showing the highest stability after 96 to 168 h at 37 C. In contrast, MeO-DOTA-CC49 labeled with all three radiolanthanides was >92% stable to hydroxyapatite challenge for 168 h at 37 C. Comprehensive biodistributions of 149Pm-, 166Ho-, and 177Lu-MeO-DOTA-CC49 were obtained in LS174T-bearing nude mice. Maximum tumor uptakes were 100.0% ID/g for 149Pm at 96 h, 69.5% ID/g for 166Ho at 96 h, and 132.4% ID/g for 177Lu at 168 h. Normal organ uptakes were generally low, except in the liver, spleen, and kidney at early time points. By 96 to 168 h postinjection, nontarget organ uptake decreased to approximately 7% ID/g (kidney), 12% ID/g (spleen), and 20% ID/g (liver) for each radiolanthanide. When labeled with 149Pm, 166Ho, and 177Lu, MeO-DOTA-CC49 has potential for RIT of colorectal cancer and other carcinomas.
Asunto(s)
Anticuerpos Antineoplásicos , Antineoplásicos , Compuestos Heterocíclicos con 1 Anillo , Elementos de la Serie de los Lantanoides/química , Neoplasias , Radioisótopos , Animales , Anticuerpos Antineoplásicos/química , Anticuerpos Antineoplásicos/metabolismo , Antineoplásicos/química , Antineoplásicos/metabolismo , Quelantes/química , Quelantes/metabolismo , Compuestos Heterocíclicos con 1 Anillo/química , Compuestos Heterocíclicos con 1 Anillo/metabolismo , Holmio/química , Humanos , Lutecio/química , Ratones , Ratones Desnudos , Estructura Molecular , Neoplasias/inmunología , Neoplasias/radioterapia , Prometio/química , Radioisótopos/química , Radioisótopos/metabolismo , Distribución TisularRESUMEN
A new amide tripodal ligand, 6-[2-(2-diethylamino-2-oxoethoxy)ethyl]-N,N,12-triethyl-11-oxo-3,9-dioxa-6,12-diazatetradecanamide (4) has been designed and synthesized for the recognition of rare earth ions. Three representative complexes of trivalent lighter (La), middle (Gd), and heavier (Er) rare earth ions with 4 were synthesized and characterized by X-ray crystallography. In the complex, the heptadentate forms a cup-like coordination cavity encapsulating the central ion. Different supramolecular complex dimers are constructed by pi-pi interaction and van der Waals forces in accordance with the lanthanide contraction. The differences of the cavity and dimer structures were investigated further by assessing the separation efficiency of in multitrace solvent extraction of rare earth ions from picrate acid solution and the ligand has the best separation factor for 147Pm(III).
Asunto(s)
Compuestos Organometálicos , Prometio/química , Cristalografía por Rayos X , Ligandos , Modelos Moleculares , Estructura Molecular , Compuestos Organometálicos/síntesis química , Compuestos Organometálicos/químicaRESUMEN
Several aminocarboxylate complexes of the "no carrier added" (NCA) radiolanthanides (149)Pm, (166)Ho and (177)Lu were evaluated using our in vitro hydroxyapatite and serum stability model and in vivo in normal CF-1 mice [10]. The aminocarboxylate chelates evaluated with the NCA radiolanthanides for in vitro stability were EDTA, CDTA, DTPA, MA-DTPA and DOTA. In addition, the NCA radiolanthanide complexes with DTPA-octreotide (DTPA-OCT) were synthesized and evaluated, as a model for a peptide conjugated aminocarboxylate complex. The biodistribution studies of the NCA complexes with DTPA, DOTA and DTPA-OCT showed that the in vitro model correctly predicted the in vivo stability of the radiolanthanide complexes, with Ln-DOTA > Ln-DTPA > Ln-DTPA-OCT.